Clinical Trial Update: GCC Agonist Signal in the Small Intestine [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update from University of Wisconsin–Madison evaluating a guanylate cyclase-C agonist signal in the small intestine for Barrett's esophagu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Barrett Esophagus
• Digestive System Neoplasms
• Gastroesophageal Reflux Disease

Drugs mentioned

• GCC agonist (guanylate cyclase-C agonist)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Barrett Esophagus, Gastroesophageal Reflux Disease | Phase 1 | Status: COMPLETED